Last reviewed · How we verify
NCT05519553: PAIR-SEP
Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
NA trial testing Peer support in Multiple Sclerosis, Relapsing-remitting in 60 participants. Status unknown.
1 March 2024
Quick facts
| Lead sponsor | Nantes University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 1 November 2022 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 March 2026 |
Drugs / interventions tested
- Peer support
Conditions studied
- Multiple Sclerosis, Relapsing-remitting — all drugs for Multiple Sclerosis, Relapsing-remitting →
Sponsor
Nantes University Hospital
Who can join
Adults 18 to 95, any sex, with Multiple Sclerosis, Relapsing-remitting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A mixed methods randomized controlled trial pilot study to assess peer support impact on relapsing-remitting multiple sclerosis patients' therapeutic adherence.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Peer support impact on therapeutic adherence in patients with multiple sclerosis: a mixed-methods pilot trial protocol.
Guilmault L, Wiertlewski S, Malloggi L, Rousseau C, et al · · 2023 · cited 1× · PMID 38159942 · DOI 10.1136/bmjopen-2022-071336
Verify or expand the search:
- PubMed search for NCT05519553
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Peer support
Trials testing the same drug.
- NCT07025109 — Assessing Peer Support for Physical Activity in Women With HIV and Hypertension · NA · recruiting
- NCT06677905 — SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation · NA · recruiting
- NCT05133726 — Peer and Text Message Support to Reduce Readmission Rates for Patients Discharged From Acute Psychiatric Care · NA · active not recruiting
- NCT04856241 — Making Football Safer for Women: Implementing an Injury Prevention Program · NA · unknown
- NCT04481737 — Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery · NA · completed
Other Nantes University Hospital trials
Trials by the same sponsor.
- NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
- NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
- NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05519553 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
- Last refreshed: 1 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05519553.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing